Targeting CD20+ Rituxan resistant B-cells with anti-CD3 activated T cells (ATC) armed with anti-CD3 x anti-CD20 (CD20Bi)

被引：0
|
作者：
Gall, JM
Grabert, RC
Deavers, M
Davoll, PA
Lum, LG
机构：
[1] Roger Williams Med Ctr, Providence, RI USA
[2] Boston Univ, Boston, MA 02215 USA
来源：
EXPERIMENTAL HEMATOLOGY | 2004年 / 32卷 / 07期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
19
引用
收藏
页码：35 / 35
页数：1
相关论文
共 50 条
  • [1] BLOCKING B-CELLS (ANTI-CD20/ANTI-CD20)
    Isenberg, David A.
    RHEUMATOLOGY, 2015, 54 : 1 - 1
  • [2] T cells armed with anti-CD3 x anti-CD20 bispecific antibody enhance killing of CD20+ malignant B cells and bypass complement-mediated rituximab resistance in vitro
    Gall, JM
    Davol, PA
    Grabert, RC
    Deaver, M
    Lum, LG
    EXPERIMENTAL HEMATOLOGY, 2005, 33 (04) : 452 - 459
  • [3] Immune consolidation after stem cell transplant for CD20+ nonhodgkin's lymphoma using multiple infusions of autologous activated T cells (ATC) with anti-CD3 x anti-CD20 bispecific antibody (CD20Bi) to improve graft-vs-lymphoma effects
    Lum, LG
    Davol, P
    Colvin, G
    Rathore, R
    Ahedi, M
    Palushock, E
    Olsen, A
    Tarro, T
    Quesenbery, P
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2006, 12 (02) : 119 - 119
  • [4] Phase I Dose Esclation of Activated T Cells (ATC) Armed with Anti-CD3 x Anti-CD20 Bispecific Antibody (CD20Bi) after Stem Cell Transplant (SCT) In Non-Hodgkin's Lymphoma (NHL)
    Lum, Lawrence G.
    Ratanatharathorn, Voravit
    Thakur, Archana
    Al-Kadhimi, Zaid
    Skuba, Cassara
    Paul, Elyse N.
    Steele, Patricia A.
    Ayash, Lois
    Abidi, Muneer H.
    Uberti, Joseph P.
    BLOOD, 2010, 116 (21) : 216 - 217
  • [5] TARGETING MYELOMA STEM CELLS WITH T CELLS ARMED WITH ANTI-CD3 X ANTI-CD20 BISPECIFIC ANTIBODY (CD20BI) PRIOR TO ASCT LEADS TO DEVELOPMENT OF ANTI-MYELOMA IMMUNE RESPONSES POST AUTOLOGOUS STEM CELL TRANSPLANT THAT CAN BE BOOSTED WITH TARGETED T CELLS
    Lawrence, L. G.
    Archana, T.
    Muneer, A.
    Zaid, A-K
    Voravit, R.
    Jeffrey, Z.
    Lois, A.
    Elyse, P. N.
    Dana, S.
    Patricia, S. A.
    Karen, M.
    Joseph, U. P.
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2012, 18 (02) : S259 - S259
  • [6] Combination Treatment With Anti-CD20 and Oral Anti-CD3 Prevents and Reverses Autoimmune Diabetes
    Hu, Changyun
    Ding, Heynan
    Zhang, Xiaojun
    Wong, F. Susan
    Wen, Li
    DIABETES, 2013, 62 (08) : 2849 - 2858
  • [7] PHASE I CLINICAL TRIAL TARGETING CD20+NON-HODGKIN'S LYMPHOMA (NHL) AFTER AUTOLOGOUS STEM CELL TRANSPLANT WITH ANTI-CD3 x ANTI-CD20 BISPECIFIC ANTIBODY ARMED T CELLS
    Lum, L. G.
    Thakur, A.
    Ratanatharathorn, V
    Al-Kadhimi, Z.
    Paul, E.
    Skuba, C.
    Steel, P.
    Ayash, L.
    Abidi, M.
    Wedge, J.
    Uberti, J. P.
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2011, 17 (02) : S158 - S159
  • [8] Efficient inhibition of human B-cell lymphoma xenografts with an anti-CD20 X anti-CD3 bispecific diabody
    Xiong, DS
    Xu, YF
    Liu, HZ
    Peng, H
    Shao, XF
    Lai, ZZ
    Fan, DM
    Yang, M
    Han, JL
    Xie, Y
    Yang, CZ
    Zhu, ZQ
    CANCER LETTERS, 2002, 177 (01) : 29 - 39
  • [9] Immunotherapy with FBTA05 (Bi20), a trifunctional anti-CD3 x anti-CD20 antibody in recurrent childhood B-cell malignancies
    Schuster, F.
    Stanglmaier, M.
    Woessmann, W.
    Winkler, B.
    Meisel, R.
    Schlegel, P. G.
    Lindhofer, H.
    Reiter, A.
    Borkhardt, A.
    Buhmann, R.
    BONE MARROW TRANSPLANTATION, 2011, 46 : S247 - S247
  • [10] Dissection of GvHD and GvL by FBTA05, a novel trifunctional anti-CD3 x anti-CD20 antibody
    Buhmann, R.
    Stanglmaier, M.
    Simoes, B.
    Menzel, H.
    Peschel, C.
    Ruf, P.
    Lindhofer, H.
    Kolb, H. -J.
    BONE MARROW TRANSPLANTATION, 2010, 45 : S123 - S123
12345